Drug Topics

MARCH 22, 2024

Researchers aimed to address the adverse effects of veterans with COVID-19 diagnoses 18 months after infections were documented.

Documentation 154

Documentation 154

Drug Topics

JANUARY 24, 2024

days faster from COVID-19 compared to patients who received a placebo in the new study. Patients who received oral simnotrelvir recovered up to 1.5

201

201

Drug Topics

NOVEMBER 20, 2023

Rich in polyphenolic compounds like chlorogenic acid (CGA), coffee may help ward off COVID-19 infection in the post-pandemic era.

Compounding 187

Compounding 187

Drug Topics

SEPTEMBER 11, 2023

Bivalent COVID-19 vaccines by both Moderna and Pfizer-BioNTech are no longer authorized for use in the United States.

Vaccines 209

Vaccines FDA 209

European Pharmaceutical Review

MARCH 26, 2024

Moderna’s next-generation COVID-19 vaccine mRNA-1283 demonstrated a higher immune response against SARS-CoV-2, interim results from the company’s Phase III trial show. Moderna acknowledged that this patient population has the greatest risk for severe outcomes from COVID-19. Moderna’s Spikevax XBB.1.5-adapted

Vaccines 93

Vaccines Immunization 93

STAT

MARCH 22, 2024

The Food and Drug Administration on Friday authorized a new antibody to protect immunocompromised individuals against Covid-19.    The drug, known as Pemgarda and marketed by the biotech Invivyd, is the first such drug to become available since the agency pulled AstraZeneca’s Evusheld off the market in January 2023.

Immunization 145

Immunization FDA 145

Drug Topics

MARCH 4, 2024

Study findings clarifying what to expect regarding the menstrual cycle after COVID-19 vaccination could help address low vaccine uptake.

Vaccines 112

Vaccines 112

Drug Topics

MARCH 22, 2024

Four posters presented at the American Pharmacists Association Annual Meeting and Exposition explored how individuals and health care providers have been handling the COVID-19 pandemic.

110

110

STAT

MARCH 4, 2024

Having Covid-19 increases a person’s risk of developing an autoimmune disease in the year after infection, a large study out of South Korea and Japan reports, but vaccination helps decrease that risk. Read the rest…

Vaccines 145

Vaccines Medical Records 145

STAT

OCTOBER 3, 2023

The Food and Drug Administration on Tuesday authorized Novavax’s updated Covid-19 vaccine, giving Americans seeking to update their protection against the SARS-CoV-2 virus another option. based company, which has struggled to claim a share of the now dwindling Covid vaccine market — globally and within the United States.

Vaccines 145

Vaccines FDA 145

Drug Topics

OCTOBER 2, 2023

Katalin Karikó, PhD, and Drew Weissman, MD, PhD, were cited "for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19."

Vaccines 201

Vaccines 201

Drug Topics

MAY 1, 2023

Though the Omicron variant caused the most symptoms in pediatric patients, there were no differences in adverse outcomes by COVID-19 variant.

186

186

Drug Topics

FEBRUARY 9, 2023

XBB, a less severe but more contagious strain of COVID-19, has taken over as the dominant Omicron strain.

184

184

Hospital Pharmacy Europe

SEPTEMBER 25, 2023

The benefits of ensitrelvir use in patients with symptoms of long Covid and as a second-line treatment option for those hospitalised with Covid-19, have been presented at the recent European Scientific Working Group on Influenza and other Acute Respiratory Viruses’ (ESWI) Influenza Conference.

Hospitals 126

Hospitals FDA 126

Drug Topics

NOVEMBER 23, 2022

In a recent study, racial minorities of an older age with non-classic cutaneous manifestations were more often to present with juvenile idiopathic inflammatory myopathies after COVID-19 infection.

196

196

Drug Topics

OCTOBER 27, 2023

The third part of the series features HCP education on key updates in the management of COVID-19. A simulated pharmacist/patient encounter is also included which highlights best practices for incorporating FDA and CDC recommendations for patients with COVID-19.

FDA 98

FDA 98

Drug Topics

OCTOBER 11, 2023

Nonpharmaceutical interventions used during the COVID-19 pandemic may have affected the current epidemiology of respiratory infections in pediatric patients.

163

163

Pharmacy Times

NOVEMBER 30, 2023

With wider testing available, diagnosing COVID-19 has become easier and many patients now have access to important treatment options.

132

132

STAT

FEBRUARY 28, 2024

Of all the lingering symptoms of long Covid , difficulty focusing and thinking, known as brain fog , may be the most frightening and baffling. Among those with long Covid — defined as symptoms lasting more than 12 weeks after testing positive — the drop was six IQ points.

Hospitals 145

Hospitals 145

Drug Topics

JANUARY 10, 2023

Researchers at Cleveland Clinic evaluated whether a bivalent COVID-19 vaccine protects against both strains of the virus - the original virus strain and a component of the omicron variant.

Vaccines 187

Vaccines 187

Fierce Pharma

MARCH 25, 2024

officials are pressing the company to pay royalties linked to the commercialization of its lucrative Pfizer-partnered COVID-19 vaccine. . | Even as Germany's BioNTech deals with ongoing declines of its revenue and share price, it's facing another serious concern: U.S.

Vaccines 141

Vaccines 141

Drug Topics

AUGUST 2, 2023

Moderna’s mRNA-1273 vaccine was associated with a lower risk of diagnosed COVID-19 when compared to Pfizer’s BNT162b2.

Vaccines 187

Vaccines 187

Pharmacy Times

MARCH 27, 2024

Early treatment administration with this regimen also promoted a faster decrease in viral load and shorter viral shedding in patients with hematologic diseases who were positive for COVID-19.

139

139

Drug Topics

APRIL 10, 2023

relative reduction in all-cause mortality from COVID-19 at 28 days. The FDA granted the EUA based on the phase 3 trial results that demonstrated vilobelimab's efficacy compared to placebo, with a 23.9%

FDA 187

FDA 187

Pharmacy Times

JANUARY 17, 2024

Individuals that lived on a majority plant-based or vegetarian/vegan diet were 39% less likely to be infected with COVID-19.

132

132

STAT

NOVEMBER 30, 2023

The Texas attorney general has filed a lawsuit accusing Pfizer of “unlawfully” and “intentionally” misrepresenting the effectiveness of its Covid-19 vaccine and attempting to censor its critics. Pfizer did not tell the truth about their Covid-19 vaccines.” “The facts are clear.

Vaccines 136

Vaccines Pharmaceutical Companies Pharmaceutical Companies 136

Pharmafile

APRIL 9, 2024

Gilead Sciences has announced that the National Institute of Health and Care Excellence (NICE) has recommended the use of Veklury (remdesivir) for the treatment of COVID-19 in eligible adults and children.

59

59

Drug Topics

FEBRUARY 21, 2023

Researchers estimate the protection from COVID-19 reinfection based on the variant and time since a patient's previous infection.

185

185

Pharmacy Times

SEPTEMBER 11, 2023

FDA grants updated Moderna and Pfizer-BioNTech COVID-19 vaccines with emergency use authorization to target currently circulating variants of the virus.

Vaccines 149

Vaccines FDA 149

Drug Topics

OCTOBER 19, 2022

Implementing mask mandates even days earlier can cause a decrease in the number of cumulative hospitalizations due to COVID-19.

Hospitals 186

Hospitals 186

Pharmacy Times

NOVEMBER 28, 2023

Regardless of which of these vaccines patients receive, as long as they receive them according to the prescribed schedules, they can protect themselves and their community against the COVID-19 virus.

Vaccines 123

Vaccines 123

Pharmacy Times

OCTOBER 20, 2023

An overview of updated CDC ACIP recommendations for COVID-19 vaccines available through commercial channels for the 2023-2024 season.

Vaccines 123

Vaccines 123

Fierce Healthcare

FEBRUARY 13, 2024

Most alarms triggered by hospital staff’s wearable safety alert systems occurred outside of the emergency department and more often during weekdays, non-holidays, surges of COVID-19 and even during | Aggregate data from 200,000 workers' wearable duress systems suggest emerging or active violent incidents occur "throughout every part of the (..)

Hospitals 128

Hospitals 128

Pharmacy Times

OCTOBER 4, 2023

mRNA-1083 (Moderna) was found comparable to the standard dose of Fluarix (GSK) in adults aged 50 to 64 years and Fluzone HD ( Sanofi) for influenza and Spikevax (Moderna) for COVID-19.

Vaccines 149

Vaccines 149

Pharmacy Times

JUNE 2, 2023

Investigators found thinner ventricular walls, disorganized and ruptured myocardial fiber, mild inflammatory infiltration, and mild epicardia or interstitial fibrosis in the hearts of mice infected with COVID-19.

181

181

STAT

JANUARY 31, 2024

In 2022, it supported a petition before the World Trade Organization to gut intellectual property protections for Covid-19 vaccines. Read the rest…

Vaccines 126

Vaccines 126

Drug Topics

DECEMBER 5, 2022

Sydney Kirkpatrick, PharmD candidate, shares how pharmacy helped ease the burden of COVID-19 in rural areas of Nebraska.

187

187